–Intent-to-Treat Analysis Shows Statistically Significant Increase in 2-Year Survival–

CALGARY, April 14, 2016 /CNW/ – Oncolytics Biotech® Inc. (TSX: ONC) (OTCQX: ONCYF) (FRA: ONY) (“Oncolytics” or the “Company”) today announced updated results for a randomized Phase 2…